The role of calcium in the etiology of the affective disorders

Japanese Journal of Pharmacology

Volumn 77, Issue 2, 1998, Pages 107-116

  Helmeste, Daiga M ^a   Tang, Siu Wa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Affective disorder; Calcium; Intracellular signaling; Platelet; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; SEROTONIN;

AFFECTIVE NEUROSIS; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; HUMAN; HUMAN CELL; LYMPHOCYTE; NEUTROPHIL; REVIEW; THROMBOCYTE; THROMBOCYTE FUNCTION;

EID: 0031867964     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.77.107     Document Type: Review

References (82)

1. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440-3450 (1985)
2. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 361, 315-325 (1993)
3. 2+ influx. Trends Pharmacol Sci 15, 282 (1994)
4. Davis TA, Bernardo J, Lazzari K, Brennan L and Simons ER: Cytosolic calcium determination: A fluorometric technique. J Nutr Biochem 2, 102-106 (1991)
5. Vostal JG, Jackson WL and Shulman NR: Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins. J Biol Chem 266, 16911-16916 (1991)
6. Vostal JG and Shafer B: Thapsigargin-induced calcium influx in the absence of detectable tyrosine phosphorylation in human platelets. J Biol Chem 271, 19524-19529 (1996)
7. 2+-ATPase by cAMP-dependent and tyrosine phosphorylation. J Biol Chem 272, 15113-15119 (1997)
8. Babnigg G, Bowersox SR and Villereal ML: The role of pp60c-src in the regulation of calcium entry via store-operated calcium channels. J Biol Chem 272, 29434-29437 (1997)
9. 4. Science 272, 1492-1494 (1996)
10. Marks AR: Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol 272, H597-H605 (1997)
11. 2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry. Cell Calcium 13, 553-564 (1992)
12. 2+ release from internal stores in human platelets. Br J Pharmacol 119, 1361-1366 (1996)
13. Johansson JS and Haynes DH: Cyclic GMP increases the rate of the calcium extrusion pump in intact human platelets but has no direct effect on the dense tubular calcium accumulation system. Biochim Biophys Acta 1105, 40-50 (1992)
14. Nakashima S, Tohmatsu T, Hattori H, Okano Y and Nozawa Y: Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets. Biochem Biophys Res Commun 135, 1099-1104 (1986)
15. 2A receptor influences amplitude and timing of intracellular calcium mobilization. J Neurochem 68, 2186-2193 (1997)
16. Kagaya A, Mikuni M, Yamamoto H, Muraoka S, Yamawaki S and Takahashi K: Heterologous supersensitization between serotonin-2 and alpha-2-adrenergic receptor-mediated intracellular calcium mobilization in human platelets. J Neural Transm Gen Sect 88, 25-36 (1992)
17. Roevens, De Clerck F and de Chaffoy de Courcelles D: The synergistic effect of 5-hydroxytryptamine and epinephrine on human platelet is related to the activation of phospholipase C. Eur J Pharmacol (Mol Pharmacol Sect) 245, 273-280 (1993)
18. Carafoli E: The calcium pump of the plasma membrane. J Biol Chem 267, 2115-2118 (1992)
19. Kagaya A, Mikuni M, Kusumi I, Yamamoto H and Takahashi K: Serotonin-induced acute desensitization of serotonin 2 receptors in human platelets via a mechanism involving protein kinase C. J Pharmacol Exp Ther 255, 305-311 (1990)
20. Kagaya A, Mikuni M, Muraoka S, Saitoh K, Ogawa T, Shinno H, Yamawaki S and Takahashi K: Homologous desensitization of serotonin-2 receptor-stimulated intracellular calcium mobilization in C6BU-1 glioma cells via a mechanism involving calmodulin pathway. J Neurochem 61, 1050-1056 (1993)
21. Helmeste DM and Tang SW: Calmodulin antagonists bind to sodium-dependent high-affinity binding sites for tritiated imipramine. Drug Dev Res 27, 185-190 (1992)
22. Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, Baker N and Harris A: Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry 46, 632-638 (1989)
23. Dubovsky SL, Lee C, Christiano J and Murphy J: Elevated platelet intracellular calcium concentration in bipolar depression. Biol Psychiatry 29, 441-450 (1991)
24. Mikuni M, Kusumi I, Kagaya A, Kuroda Y, Mori H and Takahashi K: Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 15, 49-61 (1991)
25. 2+ response is increased in the platelets of depressed patients. Biol Psychiatry 30, 310-312 (1991)
26. Kusumi I, Koyama T and Yamashita I: Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders. Biol Psychiatry 32, 731-734 (1992)
27. Mikuni M, Kagaya A, Takahashi K and Meltzer HY: Serotonin but not norepinephrine-induced calcium mobilization is enhanced in platelets of affective disorders. Psychopharmacology (Berl) 106, 311-314 (1992)
28. 2 receptor stimulation in platelets of depressed patients. Biol Psychiatry 34, 565-568 (1993)
29. Kusumi I, Koyama T and Yamashita I: Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology (Berl) 113, 322-327 (1994)
30. Dubovsky SL, Thomas M, Hijazi A and Murphy J: Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 243, 229-234 (1994)
31. Okamoto Y, Kagaya A, Shinno H, Motohashi N and Yamawaki S: Serotonin-induced platelet calcium mobilization is enhanced in mania. Life Sci 56, 327-332 (1995)
32. Eckert A, Gann H, Riemann D, Aldenhoff J and Muller WE: Platelet and lymphocyte free intracellular calcium in affective disorders. Eur Arch Psychiatry Clin Neurosci 243, 235-239 (1994)
33. Bothwell RA, Eccleston D and Marshall E: Platelet intracellular calcium in patients with recurrent affective disorders. Psychopharmacology (Berl) 114, 375-381 (1994)
34. Tan CH, Lee HS, Kua EH and Peh LH: Resting and thrombin-stimulated cytosolic calcium in platelets of patients with alcoholic withdrawal, bipolar manic disorder and chronic schizophrenia. Life Sci 56, 1817-1823 (1995)
35. Berk M, Bodemer W, Vanoudenhove T and Butkow N: The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients. Hum Psychopharmacol Clin Exp 10, 189-193 (1995)
36. Bohus M, Forstner U, Kiefer C, Gebicke-Harter P, Timmer J, Spraul G, Wark HJ, Hecht H, Berger M and van Calker D: Increased sensitivity of the inositol-phospholipid system in neutrophils from patients with acute major depressive episodes. Psychiatry Res 65, 45-51 (1996)
37. Yamawaki S, Kagaya A, Okamoto Y, Shimizu M, Nishida A and Uchitomi Y: Enhanced calcium response to serotonin in platelets from patients with affective disorders. J Psychiatry Neurosci 21, 321-324 (1996)
38. Konopka LM, Cooper R and Crayton JW: Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients. Biol Psychiatry 39, 708-713 (1996)
39. Emamghoreishi M, Schlichter L, Li PP, Parikh S, Sen J, Kamble A and Warsh JJ: High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry 154, 976-982 (1997)
40. 2+ response in human platelets. Life Sci 48, 2405-2412 (1991)
41. Ishizaki M, Tsuritani I, Ikai E, Honda R, Ishida M and Yamada Y: Elevated cytosolic free calcium concentrations in platelets of hypertensive drinkers - a weak association with alcohol consumption. J Hum Hypertens 7, 463-466 (1993)
42. Reist C, Helmeste D, Katz M, Vu R, Albers L and Tang SW: Serotonin-stimulated intracellular calcium mobilization in platelets from alcoholic men. Psychiatry Res 57, 275-278 (1995)
43. Valtier D, Guicheney P, Baudouin-Legros M and Meyer P: Platelets in human essential hypertension: in vitro hyperreactivity to thrombin. J Hypertens 4, 551-555 (1986)
44. Lechi A, Lechi C, Bonadonna G, Sinigaglia D, Corradini P, Polignano R, Arosio E, Covi G and de Togni P: Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients. Hypertension 9, 230-235 (1987)
45. Rivera A, Conlin PR, Williams GH and Canessa ML: Elevated lymphocyte cytosolic calcium in a subgroup of essential hypertensive subjects. Hypertension 28, 213-218 (1996)
46. Eberhard M, Evequoz D and Erne P: Hypertension does not affect intracellular calcium uptake in human platelets. Am J Hypertens 9, 137-143 (1996)
47. Zicha J, Pernollet MG, Kunes J, Lacour B, Vincent M, Sassard J and Devynck MA: Alterations of cytosolic calcium in platelets and erythrocytes of Lyon hypertensive rats. Am J Hypertens 8, 842-849 (1995)
48. Zicha J, Kunes J, BenIshay D and Devynck MA: Abnormal regulation of cytosolic calcium and pH in platelets of Sabra rats in early phases of salt hypertension development. Can J Physiol Pharmacol 74, 1222-1228 (1996)
49. 2+ is not coinherited with an inferred major gene locus for hypertension (ht) in the spontaneously hypertensive rat. Am J Hypertens 10, 282-288 (1997)
50. Rabkin JG, Charles E and Kass F: Hypertension and DSM-III depression in psychiatric outpatients. Am J Psychiatry 140, 1072-1074 (1983)
51. Cho JH, Nash F, Fekete Z, Kimura M, Reeves JP and Aviv A: Increased calcium stores in platelets from African Americans. Hypertension 25, 377-383 (1995)
52. Cooper RS and Rotimi CN: Absence of back-white differences in sodium and calcium in platelets. Am J Hypertens 8, 558-564 (1995)
53. 2+ mobilization are affected in uraemia. Eur J Haematol 58, 350-356 (1997)
54. 2+ in human platelets is enhanced by total fasting. Biol Psychiatry 41, 618-620 (1997)
55. Takaya J, Iawamoto Y, Higashino H, Ishihara R and Kobayashi Y: Increased intracellular calicium and altered phorbol dibutyrate binding to intact platelets in young subjects with insulin-dependent and non-insulin-dependent diabetes mellitus. Metabolism 46, 949-953 (1997)
56. Seres I, Freyssbeguin M, Mohacsi A, Kozlovszky B, Simon J, Devynck MA and Fulop T Jr: Alteration of lymphocyte membrane phospholipids intracellular free calcium concentrations in hyperlipidemic subjects. Atherosclerosis 121, 175-183 (1996)
57. Shimizu M, Nishida A and Yamawaki S: Antidepressants inhibit spontaneous oscillations of intracellular calcium concentration in rat cortical cultured neurons Neurosci Lett 146, 101-104 (1992)
58. Lavoie PA, Beauchamp G and Elie R: Absence of stereoselectivity of some tricyclic antidepressants for the inhibition of depolarization-induced calcium uptake in rat cingulate cortex synaptosomes. J Psychiatry Neurosci 19, 208-212 (1994)
59. 2+-channel inhibition. Life Sci 50, 2125-2138 (1992)
60. Shimizu M, Nishida A, Hayakawa H and Yamawaki S: Calcium release from inositol 1,4,5-trisphosphate-sensitive calcium store by antidepressant drugs in cultured neurons of rat frontal cortex. J Neurochem 60, 595-601 (1993)
61. Yamaji T, Kagaya A, Okamoto Y, Hayashi T, Motohashi N and Yamawaki S: Effects of clomipramine and verapamil on 5HT-induced intracellular calcium changes in individual C6 rat glioma cells. Neuropsychobiology 33, 55-59 (1996)
62. 2C receptors. Biol Psychiatry 39, 1000-1008 (1996)
63. 2+ mobilization in platelets. Eur J Pharmacol 288, 373-377 (1995)
64. 45Ca uptake in synaptosomes from rat hippocampus. Psychopharmacology (Berl) 110, 133-139 (1993)
65. Beauchamp G, Lavoie PA and Elie R: Differential effect of desipramine and 2-hydroxydesipramine on depolarization-induced calcium uptake in synaptosomes from rat limbic sites. Can J Physiol Pharmacol 73, 619-623 (1995)
66. Juneja R, Ueno H, Segal SJ and Koide SS: Regulation of serotonin-induced calcium uptake in Spisula oocytes by tricyclic antidepressants. Neurosci Lett 151, 101-103 (1993)
67. 2+-regulated myosin phosphorylation by fluoxetine and iprindole. Eur J Pharmacol 121, 65-71 (1986)
68. 2 receptor function in the brain of the guinea pig. Neuropharmacology 32, 249-256 (1993)
69. Sanders-Bush E, Breeding M, Knoth K and Tsutsumi M: Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology 99, 64-69 (1989)
70. Kagaya A, Kugaya A, Hayashi T, Okamoto Y, Takebayashi M, Uchitomi Y and Yamawaki S: Effect of citalopram on the desensitization of serotonin-2A receptor-mediated calcium mobilization in rat glioma cells. Prog Neuropsychopharmacol Biol Psychiatry 20, 157-166 (1996)
71. 2+ channel blockade modulate the antidepressant-induced changes in mechanisms of adrenergic transduction? J Neural Transm 104, 535-547 (1997)
72. + in rat frontocortical neurons. Neuropsychobiology 33, 66-70 (1996)
73. Kusumi I, Koyama T and Yamashita I: Effect of mood stabilizing agents on agonist-induced calcium mobilization in human platelets. J Psychiatry Neurosci 19, 222-225 (1994)
74. Yamaji T, Kagaya A, Uchitomi Y, Yokota N and Yamawaki S: Chronic treatment with antidepressants, verapamil, or lithium inhibits the serotonin-induced intracellular calcium response in individual C6 rat glioma cells. Life Sci 60, 817-823 (1997)
75. De Vry J, Fritze J and Post RM: The management of coexisting depression in patients with dementia: potential of calcium channel antagonists. Clin Neuropharmacol 20, 22-35 (1997)
76. Masters JC: When lithium does not help: the use of anticonvulsants and calcium channel blockers in the treatment of bipolar disorder in the older person. Geriatric Nursing 17, 75-78 (1996)
77. Dubovsky SL: Approaches to developing new anxiolytics and antidepressants. J Clin Psychiatry 54, Suppl, 75-83 (1993)
78. Brown NL, Sirugue O and Worcel M: The effects of some slow channel blocking drugs on high affinity serotonin uptake by rat brain synaptosomes. Eur J Pharmacol 123, 161-165 (1986)
79. Rehavi M, Carmis R and Weizman A: Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter. Eur J Pharmacol 155, 1-9 (1988)
80. Adlersberg S, Toren P, Mester R, Rehavi M, Skolnick P and Weizman A: Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants. Clin Neuropharmacol 17, 294-297 (1994)
81. Wendling WW and Harakal C: Effects of calcium antagonists on isolated bovine cerebral arteries: inhibition of constriction and calcium-45 uptake induced by potassium or serotonin. Stroke 18, 591-598 (1987)
82. DePetrillo PB, Abernethy DR, Wainer IW and Andrawis NS: Verapamil decreases lymphocyte protein kinase C activity in humans. Clin Pharmacol Ther 55, 44-49 (1994)